VeriMomsalix alba extract est-il sûr pendant la grossesse ?
No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
Alternatives sûres à salix alba extract pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- salix alba extract est-il sûr pendant la grossesse ?
- No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
- salix alba extract est-il sûr pendant l'allaitement ?
- LactMed and other clinical sources advise avoidance of willow bark/extract during breastfeeding because salicylates can be transferred and aspirin-like compounds have documented neonatal risks; no harmonised CLP or EU ban was found for the extract itself, but clinical precaution is recommended. Topical cosmetic use would give low but measurable exposure depending on formulation and concentration. (LactMed; WebMD; ECHA registration).
- salix alba extract est-il sûr pour la peau de bébé ?
- No specific infant dermal reproductive toxicity data were identified and no harmonised CLP or EU ban applies. Because the extract contains salicylates (which can be systemically active) there is a class-based concern (h=1) and a demonstrated metabolic pathway to salicylic acid (m=2). Dermal exposure in infants is higher relative to adults (immature barrier and higher surface-area-to-weight), so exposure score is increased by +1 for 0–3 yr skin compared with adults. Cosmetic topical use at typical low concentrations likely yields low systemic absorption but infant exposure is higher than adult. (PubMed toxicology summaries; LactMed; ECHA registration).
- Comment VeriMom évalue-t-il salix alba extract ?
- VeriMom évalue salix alba extract à 60/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à salix alba extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à salix alba extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.